keyword
https://read.qxmd.com/read/38614263/network-pharmacology-analysis-and-experimental-verification-of-the-antithrombotic-active-compounds-of-trichosanthis-pericarpium-gualoupi-in-treating-coronary-heart-disease
#21
JOURNAL ARTICLE
Kai-Rou Xia, Xiao-Yu Zhang, Huang-Qin Zhang, Ke-Lei Su, Er-Xin Shang, Qing-Ling Xiao, Wei-Wen Li, Sheng Guo, Jin-Ao Duan, Pei Liu
ETHNOPHARMACOLOGICAL RELEVANCE: Trichosanthis pericarpium (TP; Gualoupi, pericarps of Trichosanthes kirilowii Maxim) has been used in traditional Chinese medicine (TCM) to reduce heat, resolve phlegm, promote Qi, and clear chest congestion. It is also an essential herbal ingredient in the "Gualou Xiebai" formula first recorded by Zhang Zhongjing (from the Eastern Han Dynasty) in the famous TCM classic "Jin-Guì-Yào-Lüe" for treating chest impediments. According to its traditional description, Gualou Xiebai is indicated for symptoms of chest impediments, which correspond to coronary heart diseases (CHD)...
April 13, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38612796/unified-methodology-for-the-primary-preclinical-in-vivo-screening-of-new-anticoagulant-pharmaceutical-agents-from-hematophagous-organisms
#22
JOURNAL ARTICLE
Maria A Kostromina, Elena A Tukhovskaya, Elvira R Shaykhutdinova, Yuliya A Palikova, Viktor A Palikov, Gulsara A Slashcheva, Alina M Ismailova, Irina N Kravchenko, Igor A Dyachenko, Evgeniy A Zayats, Yuliya A Abramchik, Arkady N Murashev, Roman S Esipov
The development of novel anticoagulants requires a comprehensive investigational approach that is capable of characterizing different aspects of antithrombotic activity. The necessary experiments include both in vitro assays and studies on animal models. The required in vivo approaches include the assessment of pharmacokinetic and pharmacodynamic profiles and studies of hemorrhagic and antithrombotic effects. Comparison of anticoagulants with different mechanisms of action and administration types requires unification of the experiment scheme and its adaptation to existing laboratory conditions...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611422/clovamide-and-its-derivatives-bioactive-components-of-theobroma-cacao-and-other-plants-in-the-context-of-human-health
#23
REVIEW
Joanna Kolodziejczyk-Czepas
Clovamide ( N -caffeoyl-L-3,4-dihydroxyphenylalanine, N -caffeoyldopamine, N -caffeoyl-L-DOPA) is a derivative of caffeic acid, belonging to phenolamides (hydroxycinnamic acid amides). Despite a growing interest in the biological activity of natural polyphenolic substances, studies on the properties of clovamide and related compounds, their significance as bioactive components of the diet, as well as their effects on human health are a relatively new research trend. On the other hand, in vitro and in vivo evidence indicates the considerable potential of these substances in the context of maintaining human health or using them as pharmacophores...
April 6, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38610651/a-prospective-observational-study-on-gastric-endoscopic-submucosal-dissection-under-continuous-administration-of-antithrombotic-agents
#24
JOURNAL ARTICLE
Daisuke Kawai, Masaya Iwamuro, Ryuta Takenaka, Taisuke Obata, Takashi Yamamoto, Shoichiro Hirata, Ko Miura, Koji Takemoto, Hirofumi Tsugeno, Shigeatsu Fujiki
Background : This study aimed to assess the completion rate and postoperative bleeding incidence of endoscopic submucosal dissection (ESD) for gastric tumors under continuous antithrombotic therapy. Methods : A prospective observational study was conducted including 88 patients with 100 gastric lesions who underwent gastric endoscopic submucosal dissection (ESD) and received continuous antithrombotic therapy. Additionally, retrospective data on gastric ESD in 479 patients with 534 lesions who did not receive antithrombotic therapy were collected for comparison...
March 25, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609431/unfractionated-heparin-reverses-aspirin-inhibition-of-platelets-during-coronary-artery-bypass-graft-surgery
#25
JOURNAL ARTICLE
Robert E Turnbull, Azhar Hafeez, Katrin N Sander, David A Barrett, Gavin J Murphy, Alison H Goodall
Unfractionated heparin (UFH) is an effective antithrombotic during surgery but has known adverse effects, in particular on platelets. A marked increase in platelet responsiveness has previously been observed in patients within minutes of receiving UFH, despite adequate inhibition by aspirin prior to heparin. We studied this phenomenon in patients undergoing cardiac artery bypass grafting (n = 17) to determine whether the effects of heparin were systemic or platelet-specific. All patients' platelets were fully inhibited by aspirin prior to surgery, but within 3 min of receiving heparin spontaneous aggregation and responses to arachidonic acid (AA) and ADP increased significantly (p ≥ 0...
April 13, 2024: Scientific Reports
https://read.qxmd.com/read/38608997/rationale-and-design-for-the-randomized-placebo-controlled-double-blind-trial-studying-the-effect-of-single-antiplatelet-therapy-clopidogrel-versus-dual-antiplatelet-therapy-clopidogrel-acetylsalicylic-acid-on-the-occurrence-of-atherothrombotic-events-following
#26
JOURNAL ARTICLE
Emilien C J Wegerif, Çağdaş Ünlü, Manon I Generaal, Rutger van den Bor, Peter M van de Ven, Michiel L Bots, Gert J de Borst
RATIONALE: Antiplatelet therapy (APT) is the standard of care after endovascular revascularization (EVR) in patients with peripheral artery disease (PAD). APT aims to prevent both major adverse cardiovascular events (MACE) and major adverse limb events (MALE). Nonetheless, the rates of MACE and MALE after EVR remain high. In coronary artery and cerebrovascular disease, dual APT (DAPT)compared to acetylsalicylic acid alone has proven to reduce MACE without increasing the risk of major bleeding when applied for a restricted number of weeks...
April 10, 2024: American Heart Journal
https://read.qxmd.com/read/38608552/a-comprehensive-examination-of-clinical-characteristics-and-determinants-of-long-term-outcomes-in-pediatric-cerebral-sinus-venous-thrombosis
#27
JOURNAL ARTICLE
Cemal Karakas, Isabella Herman, Stephen F Kralik, Troy A Webber, Danielle S Takacs, Saleh Bhar, Davut Pehlivan
BACKGROUND: To analyze the clinical and neuroimaging features, risk factors, treatment choices, and long-term clinical outcomes in children with cerebral sinus venous thrombosis (CSVT). METHODS: This is a retrospective cohort study of children diagnosed with CSVT between 2002 and 2018 at Texas Children's Hospital. RESULTS: A total of 183 children (male: 62.3%) with CSVT were included. The average presenting age was 7.7 years (S.D.: 5...
March 26, 2024: Pediatric Neurology
https://read.qxmd.com/read/38608116/risk-factors-for-postoperative-bleeding-following-endoscopic-submucosal-dissection-in-early-gastric-cancer-a-systematic-review-and-meta-analysis
#28
JOURNAL ARTICLE
Yuanbo Gu, Shuchang Zhao
BACKGROUND: Early gastric cancer (EGC) presents a significant challenge in surgical management, particularly concerning postoperative bleeding following endoscopic submucosal dissection. Understanding the risk factors associated with postoperative bleeding is crucial for improving patient outcomes. METHODS: Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review and meta-analysis were conducted across PubMed, Embase, Web of Science, and the Cochrane Library without publication date restrictions...
April 12, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38606583/mussel-mimetic-hydrogel-coating-with-anticoagulant-and-antiinflammatory-properties-on-a-poly-lactic-acid-vascular-stent
#29
JOURNAL ARTICLE
Biwei Qiu, Qianqian Cheng, Rukun Chen, Chunling Liu, Jinchao Qin, Qixia Jiang
Biodegradable stents are the most promising alternatives for the treatment of cardiovascular disease nowadays, and the strategy of preparing functional coatings on the surface is highly anticipated for addressing adverse effects such as in-stent restenosis and stent thrombosis. Yet, inadequate mechanical stability and biomultifunctionality limit their clinical application. In this study, we developed a multicross-linking hydrogel on the polylactic acid substrates by dip coating that boasts impressive antithrombotic ability, antibacterial capability, mechanical stability, and self-healing ability...
April 12, 2024: Biomacromolecules
https://read.qxmd.com/read/38606417/sex-differences-in-bleeding-risk-associated-with-antithrombotic-therapy-following-percutaneous-coronary-intervention
#30
REVIEW
Yoshimi Numao, Saeko Takahashi, Yoko M Nakao, Emi Tajima, Satsuki Noma, Ayaka Endo, Junko Honye, Yayoi Tsukada
Background: Antithrombotic therapy is crucial for secondary prevention of cardiovascular disease (CVD), but women with CVD may face increased bleeding complications post-percutaneous coronary intervention (PCI) under antithrombotic therapy. However, women are often underrepresented in clinical trials in this field, so evidence for sex-specific recommendations is lacking. Methods and Results: A search on PubMed was conducted for English-language articles addressing bleeding complications and antithrombotic therapy in women...
April 10, 2024: Circulation reports
https://read.qxmd.com/read/38606387/application-of-antithrombotic-drugs-in-different-age-group-patients-with-upper-gastrointestinal-bleeding
#31
JOURNAL ARTICLE
Ding Peng, Huihong Zhai
OBJECTIVE: This study aimed at exploring the safety and timing of antithrombotic drugs in different age-group patients with UGIB. METHODS: An observational study retrospectively based on the single-center database with 713 patients with UGIB. RESULT: Among the 713 patients, 62.13% were elderly patients (aged > 60 years) and the mortality was 2.9%. In elderly patients with UGIB, we found that previous medication history, resumption of medication, and time of resumption did not affect the in-hospital mortality...
2024: Gastroenterology Research and Practice
https://read.qxmd.com/read/38604705/mr-imaging-techniques-for-acute-ischemic-stroke-and-delayed-cerebral-ischemia-following-subarachnoid-hemorrhage
#32
REVIEW
Marco Colasurdo, Huanwen Chen, Dheeraj Gandhi
Acute ischemic stroke (AIS) is a leading cause of death and disability worldwide, and its prevalence is expected to increase with global population aging and the burgeoning obesity epidemic. Clinical care for AIS has evolved during the past 3 decades, and it comprises of 3 major tenants: (1) timely recanalization of occluded vessels with intravenous thrombolysis or endovascular thrombectomy, (2) prompt initiation of antithrombotic agents to prevent stroke recurrences, and (3) poststroke supportive care and rehabilitation...
May 2024: Neuroimaging Clinics of North America
https://read.qxmd.com/read/38604510/thrombosis-inhibited-by-corydalis-decumbens-through-regulating-pi3k-akt-pathway
#33
JOURNAL ARTICLE
Song Chen, Cai-Bo Tian, Li-Yu Bai, Xing-Chao He, Qin-Yu Lu, Yun-Li Zhao, Xiao-Dong Luo
ETHNOPHARMACOLOGICAL RELEVANCE: Corydalis decumbens (Thunb.) Pers. was used as stasis-eliminating medicine traditionally to treat cardiovascular disease potentially attributed to its antithrombotic effect, but lack of pharmacological research on it. AIM OF THE STUDY: To investigate the antithrombotic effect of C. decumbens and its preliminary mechanism. MATERIALS AND METHODS: A carrageenan-induced mouse thrombus model and adenosine diphosphate stimulated platelet aggregation of rabbits were used to confirm the inhibitory effect of C...
April 9, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38601246/a-tie-over-hemostatic-approach-in-emergency-department-an-alternative-option-for-recurrent-episodes-of-postoperative-intraoral-hemorrhage
#34
JOURNAL ARTICLE
Ioannis Papadiochos, Paschalis Strantzias, Malamatenia Bourazani, Aikaterini Derila, Vasileios Petsinis
OBJECTIVE: This case series aimed to describe a hemostatic technique that has been applied in patients admitted to emergency department (ED) of a tertiary hospital due to recurrent episodes of intraoral hemorrhage (IOH) after various dentoalveolar operations. The "tie-over" approach involved the intraoral use of Xeroform® gauze (as compressive bolster dressing) and the oral rinsing with a liquid mixture of hemostatic agents. MATERIALS AND METHODS: Between February 1, 2014, and July 31, 2017, we retrospectively reviewed the medical data and records of patients in ED who chiefly complained about IOH...
April 2024: Journal of Maxillofacial and Oral Surgery
https://read.qxmd.com/read/38597619/influence-of-sex-on-the-timing-of-coronary-angiography-and-the-prescription-of-antiplatelet-therapy-in-patients-with-nonst-segment-elevation-myocardial-infarction
#35
JOURNAL ARTICLE
Antonio Martínez-Guisado, Pedro Cepas-Guillén, Pablo Díez-Villanueva, María Thiscal López Lluva, Alfonso Jurado-Román, Pablo Bazal-Chacón, Martín Negreira-Caamaño, Iván Olavarri-Miguel, Ane Elorriaga, Ricardo Rivera-López, David Escribano, Pablo Salinas, Jessica Vaquero-Luna, Alicia Prieto, Lucía Pérez-Cebey, Anna Carrasquer, Isaac Llaó, Fernando José Torres Mezcúa, Teresa Giralt-Borrell, Lucía Matute-Blanco, Clara Fernández-Cordón, Clea González, Emilio Arbas-Redondo, David Aritza-Conty, Felipe Díez-Delhoyo
OBJECTIVES: To assess differences in the clinical management of nonST-segment elevation myocardial infarction (NSTEMI), including in-hospital events, according to biological sex. MATERIAL AND METHODS: Prospective observational multicenter study of patients diagnosed with NSTEMI and atherosclerosis who underwent coronary angiography. RESULTS: We enrolled 1020 patients in April and May 2022; 240 (23.5%) were women. Women were older than men on average (72...
April 2024: Emergencias: Revista de la Sociedad Española de Medicina de Emergencias
https://read.qxmd.com/read/38597172/p2y-12-inhibition-in-patients-requiring-oral-anticoagulation-after-percutaneous-coronary-intervention-the-swap-ac-2-study
#36
JOURNAL ARTICLE
Luis Ortega-Paz, Wilbert Bor, Francesco Franchi, Wout W A van de Broek, Fabiana Rollini, Salvatore Giordano, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Haroutioun Garabedian, Tala Al Saleh, Ekin Uzunoglu, Xuan Zhou, Andrea Rivas, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Madeline K Mahowald, Calvin Y Choi, Martin M Zenni, Fladia Phoenix, Ramzi A Ajjan, Jurrien M Ten Berg, Dominick J Angiolillo
BACKGROUND: Among patients treated with a novel oral anticoagulant (NOAC) undergoing percutaneous coronary intervention (PCI), combination therapy with clopidogrel (i.e., known as dual antithrombotic therapy [DAT]) is the treatment of choice. However, there are concerns for individuals with impaired response to clopidogrel. OBJECTIVES: To assess the pharmacodynamic (PD) effects of clopidogrel vs. low-dose ticagrelor in patients with impaired clopidogrel response assessed by the ABCD-GENE score...
April 1, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38596067/antithrombotic-pharmacodynamics-and-metabolomics-study-in-raw-and-processed-products-of-whitmania-pigra-whitman
#37
JOURNAL ARTICLE
Hongqian Kui, Yan Lei, Chunxue Jia, Quancheng Xin, Rustam Tursun, Miao Zhong, Chuanxin Liu, Ruijuan Yuan
OBJECTIVE: As a traditional Chinese medicine, leech has obvious pharmacological activities in anticoagulantion and antithrombosis. Whitmania pigra Whitman (WP) is the most commonly used leech in the Chinese market. It is often used in clinical applications after high-temperature processing by talcum powder to remove the fishy taste and facilitate crushing. The anticoagulant and thrombolytic active ingredients are protein and polypeptide, which may denaturate and lose activity after high-temperature processing...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38594458/de-escalation-of-antithrombotic-treatment-after-acute-coronary-syndrome-a-new-paradigm
#38
REVIEW
Andrea Rubboli, Dan Atar, Dirk Sibbing
After an acute coronary syndrome (ACS) it is imperative to balance the bleeding vs. the ischemic risk given the similar prognostic impact of the two events. Since the post-discharge bleeding risk is substantially stable over time whereas the ischemic risk accumulates in the first weeks to months, a strategy of de-escalation of antithrombotic treatment, consisting in the reduction of either the duration (i.e., early interruption of one antiplatelet agent) or the intensity (i.e., switching from the more potent P2Y12 -inhibitors prasugrel or ticagrelor to clopidogrel) of dual antiplatelet therapy (DAPT), has been proposed...
April 10, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38594156/methodologic-quality-and-pharmacotherapy-recommendations-for-patient-blood-management-guidelines-for-cardiac-surgery-on-cardiopulmonary-bypass
#39
REVIEW
Xiaojing Huang, Pengqiang Du, Haipan Jia, Aifeng Wang, Ying Hua, Xuelan Liu, Kaiyuan Wu, Bin Li, Hongwei Zhao
Patient blood management (PBM) guidelines for patients undergoing cardiac surgery under cardiopulmonary bypass (CPB) have increased during the past decade, and pharmacotherapy plays an important role in PBM. In the face of the undefined consistency in the methodologic quality and pharmacotherapy recommendations across multiple guidelines, this study exclusively evaluated methodologies of the related guideline development process, and compiled medication recommendations of PBM for cardiac surgery patients. PBM guidelines for cardiac surgery under CPB were searched through some mainstream literature and guideline databases from database establishment to May 15, 2023...
March 12, 2024: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38592348/a-non-coronary-peripheral-arterial-atherosclerotic-disease-carotid-renal-lower-limb-in-elderly-patients-a-review-part-ii-pharmacological-approach-for-management-of-elderly-patients-with-peripheral-atherosclerotic-lesions-outside-coronary-territory
#40
REVIEW
Marcin Piechocki, Tadeusz Przewłocki, Piotr Pieniążek, Mariusz Trystuła, Jakub Podolec, Anna Kabłak-Ziembicka
Aging is a key risk factor for atherosclerosis progression that is associated with increased incidence of ischemic events in supplied organs, including stroke, coronary events, limb ischemia, or renal failure. Cardiovascular disease is the leading cause of death and major disability in adults ≥ 75 years of age. Atherosclerotic occlusive disease affects everyday activity, quality of life, and it is associated with reduced life expectancy. As most multicenter randomized trials exclude elderly and very elderly patients, particularly those with severe comorbidities, physical or cognitive dysfunctions, frailty, or residence in a nursing home, there is insufficient data on the management of older patients presenting with atherosclerotic lesions outside coronary territory...
March 5, 2024: Journal of Clinical Medicine
keyword
keyword
73912
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.